tradingkey.logo

tradingkey.logo
怜玢


DaVita Inc

DVA
りォッチリストに远加
240.090USD
+1.260+0.53%
終倀 07-31 16:00ET15分遅れの株䟡
16.46B時䟡総額
21.95盎近12ヶ月PER

詳现情報 DaVita Inc 䌁業名

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

DaVita Incの䌁業情報


䌁業コヌドDVA
䌚瀟名DaVita Inc
䞊堎日Oct 31, 1995
最高経営責任者「CEO」Rodriguez (Javier J)
埓業員数76000
蚌刞皮類Ordinary Share
決算期末Oct 31
本瀟所圚地2000 16th St
郜垂DENVER
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United States of America
郵䟿番号80202-5117
電話番号13105362668
りェブサむトhttps://www.davita.com/
䌁業コヌドDVA
䞊堎日Oct 31, 1995
最高経営責任者「CEO」Rodriguez (Javier J)

DaVita Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
775.74K
-8.95%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
110.08K
-46.76%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
90.89K
-16.95%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.95K
+0.93%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
26.55K
-77.32%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
19.61K
+18.61%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
15.53K
-101.43%
Ms. Barbara J. Desoer
Ms. Barbara J. Desoer
Independent Director
Independent Director
14.02K
+1.78%
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
9.53K
-50.27%
Dr. Gregory J. Moore, M.D., Ph.D.
Dr. Gregory J. Moore, M.D., Ph.D.
Independent Director
Independent Director
7.81K
+3.20%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
775.74K
-8.95%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
110.08K
-46.76%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
90.89K
-16.95%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.95K
+0.93%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
26.55K
-77.32%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
19.61K
+18.61%

よくある質問

DaVita Incの䞊䜍5名の株䞻は誰ですか


DaVita Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Javier J. Rodriguez

DaVita IncDVAの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、DaVita Incの株匏を保有しおいる機関は1310瀟あり、保有株匏の総垂堎䟡倀は玄36.02Mで、党䜓の56.10%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-3261619.00増加しおいたす。

DaVita Incの最倧の収益源は䜕ですか


2026Q1においお、Patient service - Medicare and Medicare Advantage郚門がDaVita Incにずっお最倧の収益を生み出しおおり、その金額は6.74Bで、党収益の49.41%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。